tiprankstipranks
Lipocine (LPCN)
NASDAQ:LPCN
US Market

Lipocine (LPCN) Stock Investors

872 Followers
Based on 744,106 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold LPCN
On average, investors allocate 0.00% of their portfolios to LPCN
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 744,106 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding LPCN

1.6%
Last 7
Days
18.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding LPCN, out of 744,106 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

LPCN Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$3.64
Based on the activity of 14,093 investors who made their portfolios public
The table shows changes in LPCN in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

LPCN Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.79%
-0.59%
-1.56%
32.86B
Consumer Cyclical
ChargePoint Holdings
4.10%
-1.13%
-2.11%
706.00M
Consumer Cyclical
Marathon Digital Holdings
5.65%
-0.36%
-1.13%
5.73B
Financial
Assertio Therapeutics
2.81%
-1.55%
-4.91%
129.37M
Healthcare
Riot Platforms
4.93%
-0.44%
-0.45%
2.76B
Financial
Blink Charging Co
5.18%
-1.42%
-4.42%
281.96M
Industrials
Plug Power
4.99%
-1.16%
-2.94%
1.83B
Industrials
GE Aerospace
5.28%
+0.09%
+0.93%
178.42B
Industrials
XPeng, Inc. ADR
5.35%
-1.13%
-2.98%
7.55B
Consumer Cyclical
AMC Entertainment
5.70%
-1.43%
-2.12%
1.49B
Communication Services
Based on the activity of 744,106 active portfolios
Open your Smart Portfolio

LPCN Investor Analysis

LPCN investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.1%
of LPCN holders
are under 35
Average Segment Performance
Average P/E Ratio21.46
Beta7.39
Dividend Yield6.06%
LPCN investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
57.0%
of LPCN holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.66
Beta13.51
Dividend Yield6.08%
LPCN investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
27.9%
of LPCN holders
are over 55
Average Segment Performance
Average P/E Ratio20.71
Beta4.77
Dividend Yield7.20%
Overview of age group and performance of LPCN stock investors
See who invests in LPCN according to age group and performance.

FAQ

How many retail Investors hold LPCN?
<0.1% of TipRanks' retail investors hold LPCN in their portfolios.
    What is LPCN Investor Sentiment?
    LPCN’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of LPCN in the last 7 days?
      ▼ 1.6% of TipRanks' retail investors changed their holding of LPCN in the last 7 days.
        What percentage of retail investors changed their holding of LPCN in the last 30 days?
        ▲ 18.6% of TipRanks' retail investors changed their holding of LPCN in the last 30 days.
          What is the average age of retail investors who hold LPCN?
          The average age of LPCN Holders is between 35–55.
            What other stocks have LPCN investors also bought?
            LPCN Investors also bought DKNG, CHPT, MARA, ASRT, RIOT, BLNK, PLUG, GE, XPEV, AMC.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AZNAstraZeneca
              DVADaVita
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              INSMInsmed
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis